Search results for: Sir Mike Richards

OHE Awarded Funding for Seven Projects by the EuroQol Research Foundation

18 July 2016

…Bernarda Zamora, Yan Feng, Mike Herdman and Andrew Bateman (NHS Cambridgeshire Community Services). Despite widespread use of EQ-5D, the evidence base for the selection of its five dimensions is not…

OHE at EuHEA 2018

10 July 2018

…Association (EuHEA) 2018 conference in Maastricht, 11-14 July. Later this week, Graham Cookson, Paula Lorgelly, Koonal Shah, Mikel Berdud, and Margherita Neri will be travelling to Maastricht, The Netherlands, to…

OHE at the EuroQol Academy Meeting 2017

OHE’s Nancy Devlin, Yan Feng, Mike Herdman and Koonal Shah all contributed to the EuroQol Academy Meeting 2017. The EuroQol Group is a global network of experts that initiated and…

OHE at iHEA Boston 2017: Meet the Team

5 July 2017

…shows the added value of vignettes to patient reported outcome measures like the EQ-5D as well as other self-reported health responses. OHE Presenter: Mikel Berdud Time & Date: Tuesday 11th…

New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions

10 May 2016

…OHE Consulting Report. London: Office of Health Economics. Horton, R., 2010. GBD 2010: understanding disease, injury, and risk. Lancet, 380, pp. 2053–4. Murray, C., Richards, M., Newton, J., Fenton, K.,…

Value and Cancer: Journal of Cancer Policy Special Issue

25 January 2017

…J.C., Hernandez-Villafuerte, K., Shah, K., Mestre-Ferrandiz, J., Garrison, L. and Towse, A., 2014. The Expanding Value Footprint of Oncology Treatments. Consulting Report. London: Office of Health Economics. Richards, M., 2011. Achieving…

Our Contributions to the Economics of Personalised Medicine

7 March 2018

…Ashley D, Hayes T, McMurrick P, Richardson G, Lorgelly P,  Fox SB, Thomas DM (2015). Cancer 2015: A prospective, population-based cancer cohort – Phase 1: feasibility of genomics-guided precision medicine…

An eye on sustainability at the Economist’s Future of Health Europe

30 October 2023

…true meaning of ‘healthcare’ as not just being ‘illness care’. Although the current system favours a curative approach to health, Glynn Richards (Bupa) declared that preventative medicine is fundamentally the…

The commercial case for investing in ALS

13 November 2025

…by 10-16 months from symptom onset due to symptom heterogeneity and the absence of reliable biomarkers (Richards, Morren and Pioro, 2020). Only three disease-modifying therapies (DMTs) have been approved to date,…